Review of oral cholera vaccines: efficacy in young children
- PMID: 22114507
- PMCID: PMC3215343
- DOI: 10.2147/IDR.S10339
Review of oral cholera vaccines: efficacy in young children
Abstract
Background: Young children are one of the most vulnerable groups who may be infected with cholera. The following literature review of the efficacy of the currently available cholera vaccines provides a clear evidence base for the clinical administration of cholera vaccine, particularly in an epidemic situation.
Aim: To assess the efficacy of oral cholera vaccines in preventing cases of cholera in young children.
Methods: A systematic literature review was undertaken for the period 1983 to 2011 using PubMed and the search terms "oral cholera vaccines," "children," and "efficacy," limited to "clinical trials" and "human studies".
Results: Oral cholera vaccine provides an acceptable level of protection in young children, with the level of protection being greater at 12 or 24 months following immunization.
Conclusions: Children exposed to a potential risk of cholera are recommended to be vaccinated with an oral cholera vaccine, irrespective of whether its constituents include the B subunit.
Keywords: children; efficacy; oral cholera vaccine.
Similar articles
-
Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.Lancet. 1997 Jan 25;349(9047):231-5. doi: 10.1016/s0140-6736(96)06107-7. Lancet. 1997. PMID: 9014909 Clinical Trial.
-
Field trial of oral cholera vaccines in Bangladesh.Lancet. 1986 Jul 19;2(8499):124-7. doi: 10.1016/s0140-6736(86)91944-6. Lancet. 1986. PMID: 2873397 Clinical Trial.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.Lancet. 2005 Jul 2-8;366(9479):44-9. doi: 10.1016/S0140-6736(05)66550-6. Lancet. 2005. PMID: 15993232
-
Oral cholera vaccine--for whom, when, and why?Travel Med Infect Dis. 2006 Jan;4(1):38-42. doi: 10.1016/j.tmaid.2004.12.002. Travel Med Infect Dis. 2006. PMID: 16887724 Review.
Cited by
-
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.J Prev Med Hyg. 2019 Dec 20;60(4):E271-E285. doi: 10.15167/2421-4248/jpmh2019.60.4.1333. eCollection 2019 Dec. J Prev Med Hyg. 2019. PMID: 31967084 Free PMC article. Review.
-
Updated global burden of cholera in endemic countries.PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. doi: 10.1371/journal.pntd.0003832. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26043000 Free PMC article.
-
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.Sci Rep. 2016 Oct 24;6:35742. doi: 10.1038/srep35742. Sci Rep. 2016. PMID: 27775046 Free PMC article.
-
Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.Vaccine. 2015 Jul 17;33(31):3709-16. doi: 10.1016/j.vaccine.2015.05.091. Epub 2015 Jun 10. Vaccine. 2015. PMID: 26072016 Free PMC article.
-
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.Clin Vaccine Immunol. 2014 Sep;21(9):1195-205. doi: 10.1128/CVI.00378-14. Epub 2014 Jul 23. Clin Vaccine Immunol. 2014. PMID: 25056361 Free PMC article. Review.
References
-
- World Health Organization Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(13):117–128. - PubMed
-
- Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007;7(8):521–530. - PubMed
-
- Tacket CO, Sack DA. Cholera vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders Elsevier; 2008. pp. 127–138.
-
- Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006;6(6):361–373. - PubMed
LinkOut - more resources
Full Text Sources
